Shopping Cart
- Remove All
- Your shopping cart is currently empty
Brigimadlin (BI 907828) is an orally active and highly potent E3 ubiquitin-protein ligase
MDM2-p53 antagonist with antitumor activity.Brigimadlin can be used to study metastatic BTC, PDAC, lung adenocarcinoma, or bladder cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $270 | In Stock | |
5 mg | $590 | In Stock | |
10 mg | $890 | In Stock | |
25 mg | $1,520 | In Stock | |
50 mg | $1,980 | In Stock |
Description | Brigimadlin (BI 907828) is an orally active and highly potent E3 ubiquitin-protein ligase MDM2-p53 antagonist with antitumor activity.Brigimadlin can be used to study metastatic BTC, PDAC, lung adenocarcinoma, or bladder cancer. |
In vitro | Brigimadlin (at concentrations ranging from 0-10 nM; over 48 hours) inhibits the proliferation of BT48, BT50, BT67, BT69, BT89, and BT94, with respective IC50 values of 58.5, 21.1, 37.9, 89.8, 16.7, and 46.8 pM[1]. |
Alias | BI-907828, BI907828, BI 907828 |
Molecular Weight | 591.46 |
Formula | C31H25Cl2FN4O3 |
Cas No. | 2095116-40-6 |
Smiles | C(N1[C@@]2([C@H]([C@]3([C@@]1(CC=4N3N=C5C4C=CC(C(O)=O)=C5C)[H])[H])C6=C(F)C(Cl)=CC=C6)C=7C(NC2=O)=CC(Cl)=CC7)C8CC8 |
Storage | keep away from direct sunlight,store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.